Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1218
http://purl.obolibrary.org/obo/NCIT_C1218
|
|---|---|
| Preferred Name | Rhizoxin |
| Definitions |
A macrocyclic lactone. Rhizoxin binds to tubulin and inhibits microtubule assembly, thereby inducing cytotoxicity. This agent also may inhibit endothelial cell-induced angiogenic activity, which may result in decreased tumor cell proliferation. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A macrocyclic lactone. Rhizoxin binds to tubulin and inhibits microtubule assembly, thereby inducing cytotoxicity. This agent also may inhibit endothelial cell-induced angiogenic activity, which may result in decreased tumor cell proliferation. (NCI04) |
|---|---|
| prefLabel | Rhizoxin
|
| label | Rhizoxin
|
| PDQ_Closed_Trial_Search_ID | 41718
|
| code | C1218
|
| prefixIRI | NCIT:C1218
|
| in_subset | |
| Preferred_Name | Rhizoxin
|
| FDA_UNII_Code | C1V1Y784E4
|
| Contributing_Source | FDA
|
| Maps_To | Rhizoxin
|
| CAS_Registry | 90996-54-6
|
| NSC Number | 332598
|
| NCI_Drug_Dictionary_ID | 41718
|
| Legacy Concept Name | Rhizoxin
|
| type | |
| ALT_DEFINITION | A substance that is being studied in the treatment of cancer. It comes from a fungus and is similar to vinca alkaloid drugs. It belongs to the family of drugs called antimitotic agents.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 41718
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
Antibiotic
|
| UMLS_CUI | C0073184
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |